BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 7, 2026; 32(45): 120646
Published online Dec 7, 2026. doi: 10.3748/wjg.120646
Table 5 Multivariate Cox proportional hazards model for patients with inflammatory bowel disease taking thiopurines and patients with inflammatory bowel disease taking 5-aminosalicylic acid and not taking thiopurines or biologics assessing predictors for lymphoma
Covariate
Hazard ratio (95%CI)
P value
Male1.59 (1.33-1.90)< 0.0001
Age at index
≥ 50 years1.90 (0.99-3.62)0.0527
18-50 years5.59 (2.94-10.63)< 0.0001
Race
Asian1.88 (0.99-3.57)0.0558
Black or African American1.13 (0.67-1.94)0.6445
Native Hawaiian or Other Pacific Islander1.52 (0.20-11.31)0.6840
White1.21 (0.78-1.89)0.3998
Other race2.00 (1.00-4.01)0.0502
Ethnicity
Hispanic or Latino0.75 (0.39-1.43)0.3772
Not Hispanic or Latino1.31 (1.02-1.68)0.0330
Comorbidities
Essential hypertension1.19 (0.94-1.50)0.1445
Type 2 diabetes mellitus0.97 (0.72-1.30)0.8143
Hyperlipidemia0.95 (0.73-1.23)0.6989
Tobacco use0.82 (0.35-1.90)0.6395
Alcohol use disorders1.26 (0.66-2.38)0.4868
Nicotine dependence0.95 (0.65-1.40)0.8014
Laboratory values
Total cholesterol (mg/dL)
≥ 2001.09 (0.64-1.85)0.7540
Cholesterol in LDL (mg/dL)
≥ 1501.08 (0.58-2.03)0.8031
Cholesterol in HDL (mg/dL)
≥ 500.98 (0.72-1.34)0.9204
Glycosylated hemoglobin (%)
> 6.501.95 (1.36-2.78)0.0003


Write to the Help Desk